Quzhou Aurantii Fructus Flavonoids Ameliorate Inflammatory Responses, Intestinal Barrier Dysfunction in DSS-Induced Colitis by Modulating PI3K/AKT Signaling Pathway and Gut Microbiome DOI Creative Commons
Haiou Wang, Wenkang Huang,

Xiaoya Pan

и другие.

Journal of Inflammation Research, Год журнала: 2025, Номер Volume 18, С. 1855 - 1874

Опубликована: Фев. 1, 2025

Purpose: To explore the protective effect and underlying mechanism of Quzhou Aurantii Fructus flavonoids (QAFF) on Ulcerative colitis (UC). Methods: The constituents QAFF were accurately determined by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). therapeutic impacts assessed in dextran sulfate sodium (DSS)-induced UC mice, focusing changes body weight, disease activity index (DAI), colon length, histological assessment colonic tissues, levels pro-inflammatory cytokines, expression tight junction proteins. Western blotting confirmed key regulatory proteins within differential signaling pathways, guided transcriptome analysis. Additionally, influence gut microbiome was explored through 16S ribosomal RNA (rRNA) sequencing. alterations endogenous metabolites detected untargeted metabolomics, their potential correlation with intestinal flora then examined utilizing Spearman Subsequently, regulation validated fecal microbiota transplantation (FMT). Results: Eleven flavonoids, including Naringin hesperidin, initially identified from QAFF. In vivo experiments demonstrated that effectively ameliorated symptoms, reduced IL-6, IL-1β, TNF-α levels, enhanced barrier integrity, downregulated PI3K/AKT pathway activation. Furthermore, elevated beneficial bacteria like Lachnospiraceae_NK4A136_group Alloprevotella concurrently pathogenic such as Escherichia-Shigella, [Eubacterium]_ siraeum _group , Parabacteroides . Metabolomics analysis revealed 34 exhibited significant alterations, predominantly associated Glycerophospholipid metabolism. These significantly correlated those modulated Lastly, administration via FMT symptoms. Conclusion: could ameliorate inflammatory responses dysfunction DSS-induced mice probably modulating microbiome, offering promising evidence for treatment. Keywords: colitis, inflammation, Gut microbiota, PI3K/AKT, Fecal

Язык: Английский

Caffeic Acid Supplement Alleviates Colonic Inflammation and Oxidative Stress Potentially Through Improved Gut Microbiota Community in Mice DOI Creative Commons
Fan Wan, Ruqing Zhong, Mengyu Wang

и другие.

Frontiers in Microbiology, Год журнала: 2021, Номер 12

Опубликована: Ноя. 16, 2021

Caffeic acid (CA) is one of the major phenolic acids coffee with multiple biological activities. Our previous study found that 500 mg/kg chlorogenic (CGA) had potential capacity alleviating colonic inflammation. Moreover, CGA can be degraded into caffeic by gut microbiota in colon. Therefore, we hypothesize CA exert protective effects on To test hypothesis, 251 was supplemented to DSS-induced colitis mice. The results showed treatment recovered disease activity index (DAI), colon length, and histopathology scores tissue. Additionally, significantly decreased pro-inflammatory cytokines malondialdehyde (MDA) levels increased level IL-10, total antioxidant (T-AOC), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) serum. qPCR indicated dramatically downregulated mRNA expression IL-1β, IL-6, TNF-α as well upregulated SOD1, GPX1, GPX2, CAT, IL-10. In addition, supplementation Nrf-2, HO-1, NQO1, which its anti-inflammatory capacities potentially activating Nrf-2/HO-1 pathway. prevented barrier damage enhancing Occludin gene expression. Furthermore, altered microbiome composition decreasing relative abundance Bacteroides Turicibacter, Alistipes Dubosiella. Meanwhile, increases Dubosiella Akkermansia. conclusion, could effectively alleviate improving defense against oxidative stress inflammatory response.

Язык: Английский

Процитировано

107

The role of Akkermansia muciniphila in inflammatory bowel disease: Current knowledge and perspectives DOI Creative Commons

Mengyu Zheng,

Ran Han,

Yali Yuan

и другие.

Frontiers in Immunology, Год журнала: 2023, Номер 13

Опубликована: Янв. 6, 2023

Inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, is a chronic relapsing gastrointestinal inflammatory mediated by dysregulated immune responses to resident intestinal microbiota. Current conventional approaches aminosalicylates, corticosteroids, immunosuppressive agents, biological therapies are focused on reducing inflammation besides inducing maintaining remission, managing complications. However, these not curative associated with various limitations, such as drug resistance, low responsiveness adverse events. Recent accumulated evidence has revealed the involvement of mucin-degrading bacterium

Язык: Английский

Процитировано

95

Reactive Oxygen Species‐Scavenging Nanosystems in the Treatment of Diabetic Wounds DOI
Yuan Xiong, Xiangyu Chu, Tao Yu

и другие.

Advanced Healthcare Materials, Год журнала: 2023, Номер 12(25)

Опубликована: Апрель 13, 2023

Diabetic wounds are characterized by drug-resistant bacterial infections, biofilm formation, impaired angiogenesis and perfusion, oxidative damage to the microenvironment. Given their complex nature, diabetic remain a major challenge in clinical practice. Reactive oxygen species (ROS), which have been shown trigger hyperinflammation excessive cellular apoptosis, play pivotal role pathogenesis of wounds. ROS-scavenging nanosystems recently emerged as smart multifunctional nanomedicines with broad synergistic applicability. The documented anti-inflammatory pro-angiogenic ability treatments predestines these promising options for treatment Yet, this context, therapeutic applicability efficacy be elucidated. Herein, ROS is deciphered, properties strengths capacity summarized. In addition, current challenges such potential future directions discussed through clinical-translational lens.

Язык: Английский

Процитировано

87

Drug-microbiota interactions: an emerging priority for precision medicine DOI Creative Commons
Qing Zhao, Yao Chen, Weihua Huang

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2023, Номер 8(1)

Опубликована: Окт. 9, 2023

Abstract Individual variability in drug response (IVDR) can be a major cause of adverse reactions (ADRs) and prolonged therapy, resulting substantial health economic burden. Despite extensive research pharmacogenomics regarding the impact individual genetic background on pharmacokinetics (PK) pharmacodynamics (PD), diversity explains only limited proportion IVDR. The role gut microbiota, also known as second genome, its metabolites modulating therapeutic outcomes human diseases have been highlighted by recent studies. Consequently, burgeoning field pharmacomicrobiomics aims to explore correlation between microbiota variation IVDR or ADRs. This review presents an up-to-date overview intricate interactions classical agents for systemic diseases, including cancer, cardiovascular (CVDs), endocrine others. We summarise how directly indirectly, modify absorption, distribution, metabolism, excretion (ADME) drugs. Conversely, drugs modulate composition function leading changes microbial metabolism immune response. discuss practical challenges, strategies, opportunities this field, emphasizing critical need develop innovative approach multi-omics, integrate various data types, genomic data, well translate lab into clinical practice. To sum up, represents promising avenue address improve patient outcomes, further is imperative unlock full potential precision medicine.

Язык: Английский

Процитировано

79

New insights into the mechanisms of high‐fat diet mediated gut microbiota in chronic diseases DOI Creative Commons
Jiali Chen, Yuhang Xiao, Dongmei Li

и другие.

iMeta, Год журнала: 2023, Номер 2(1)

Опубликована: Янв. 5, 2023

Abstract High‐fat diet (HFD) has been recognized as a primary factor in the risk of chronic disease. Obesity, diabetes, gastrointestinal diseases, neurodegenerative and cardiovascular diseases have long known with high worldwide incidence. In this review, influences gut microbiota their corresponding bacterial metabolites on mechanisms HFD‐induced are systematically summarized. Gut imbalance is also to increase susceptibility diseases. Several studies proven that HFD negative impact microbiota, exacerbating course many through increased populations Erysipelotrichaceae , facultative anaerobic bacteria, opportunistic pathogens. Since bile acids, lipopolysaccharide, short‐chain fatty trimethylamine N ‐oxide common features metabolites, we will explore possibility synergistic among those context Recent literature concerning mechanistic actions HFD‐mediated collected from PubMed, Google Scholar, Scopus. The aim review provide new insights into point out potential biomarkers microbiota.

Язык: Английский

Процитировано

70

Traditional Chinese Medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology DOI
Mei Wang, Rui‐Jia Fu,

Ding-Qiao Xu

и другие.

Journal of Ethnopharmacology, Год журнала: 2023, Номер 318, С. 116879 - 116879

Опубликована: Июль 5, 2023

Язык: Английский

Процитировано

52

An Engineered Butyrate-Derived Polymer Nanoplatform as a Mucosa-Healing Enhancer Potentiates the Therapeutic Effect of Magnolol in Inflammatory Bowel Disease DOI
Fan Xi, Zhuangzhuang Zhang, Wenxia Gao

и другие.

ACS Nano, Год журнала: 2023, Номер 18(1), С. 229 - 244

Опубликована: Дек. 19, 2023

Colonic epithelial damage and dysregulated immune response are crucial factors in the progression exacerbation of inflammatory bowel disease (IBD). Nanoenabled targeted drug delivery to inflamed intestinal mucosa has shown promise inducing maintaining colitis remission, while minimizing side effects. Inspired by excellent antioxidative anti-inflammatory efficacy naturally derived magnolol (Mag) gut homeostasis regulation microbiota-derived butyrate, we developed a pH/redox dual-responsive butyrate-rich polymer nanoparticle (PSBA) as an oral Mag system for combinational therapy IBD. PSBA showed high butyrate content 22% effectively encapsulated Mag. The Mag-loaded nanoparticles (PSBA@Mag) demonstrated colonic pH reduction-responsive release, ensuring efficient retention adhesion colon mice. PSBA@Mag not only normalized level reactive oxygen species effectors but also restored barrier function both ulcerative Crohn's mouse models. Importantly, promoted migration healing ability cells vitro vivo, sensitizing therapeutic animal Moreover, transcriptomics metabolism analyses revealed that mitigated inflammation suppressing production pro-inflammatory cytokines chemokines restoring lipid metabolism. Additionally, this nanomedicine modulated microbiota inhibiting pathogenic Proteus Escherichia-Shigella promoting proliferation beneficial probiotics, including Lachnoclostridium, Lachnospiraceae_NK4A136_group norank_f_Ruminococcaceae. Overall, our findings highlight potential butyrate-functionalized polymethacrylates versatile effective nanoplatforms repair combating IBD other gastrointestinal disorders.

Язык: Английский

Процитировано

45

Lachnospiraceae -derived butyrate mediates protection of high fermentable fiber against placental inflammation in gestational diabetes mellitus DOI Creative Commons
Shuangbo Huang, Jianzhao Chen, Zhijuan Cui

и другие.

Science Advances, Год журнала: 2023, Номер 9(44)

Опубликована: Ноя. 3, 2023

Inflammation-associated insulin resistance is a key trigger of gestational diabetes mellitus (GDM), but the underlying mechanisms and effective interventions remain unclear. Here, we report association placental inflammation (tumor necrosis factor–α) abnormal maternal glucose metabolism in patients with GDM, high fermentable dietary fiber (HFDF; konjac ) could reduce GDM development through gut flora–short-chain fatty acid–placental axis mouse model. Mechanistically, HFDF increases abundances Lachnospiraceae butyrate, reduces placental-derived by enhancing barrier inhibiting transfer bacterial-derived lipopolysaccharide, ultimately resists high-fat diet–induced resistance. butyrate have similar anti-GDM anti–placental effects, they can ameliorate function pregnancy outcome effects probably dampening immune dysfunction. These findings demonstrate involvement important inflammation–related progression great potential HFDFs to susceptibility gut-flora-placenta axis.

Язык: Английский

Процитировано

43

The role of gut microbiota in intestinal disease: from an oxidative stress perspective DOI Creative Commons

Yiqi Sun,

Xurui Wang,

Lei Li

и другие.

Frontiers in Microbiology, Год журнала: 2024, Номер 15

Опубликована: Фев. 14, 2024

Recent studies have indicated that gut microbiota-mediated oxidative stress is significantly associated with intestinal diseases such as colorectal cancer, ulcerative colitis, and Crohn’s disease. The level of reactive oxygen species (ROS) has been reported to increase when the microbiota dysregulated, especially several bacterial metabolites are present. Although healthy plays a vital role in defending against excessive stress, disease influenced by ROS, this process controlled immunological responses, DNA damage, inflammation. In review, we discuss relationship between from an perspective. addition, also provide summary most recent therapeutic approaches for preventing or treating modifying microbiota.

Язык: Английский

Процитировано

35

Gegen Qinlian decoction ameliorates TNBS-induced ulcerative colitis by regulating Th2/Th1 and Tregs/Th17 cells balance, inhibiting NLRP3 inflammasome activation and reshaping gut microbiota DOI

Yingnan Hu,

Jingyi Tang,

Yongfeng Xie

и другие.

Journal of Ethnopharmacology, Год журнала: 2024, Номер 328, С. 117956 - 117956

Опубликована: Фев. 29, 2024

Язык: Английский

Процитировано

18